Vor Biopharma VOR Issuance Costs Related To Private Placement Included In Accounts Payable And Accrued Expenses
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept vor:IssuanceCostsRelatedToPrivatePlacementIncludedInAccountsPayableAndAccruedExpenses.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's issuance costs related to private placement included in accounts payable and accrued expenses.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's issuance costs related to private placement included in accounts payable and accrued expenses?
- Vor Biopharma (VOR) reported issuance costs related to private placement included in accounts payable and accrued expenses of $93K in Q1 2026.